Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Phase I clinical trials].

P Jaillon1

  • 1Service de Pharmacologie, Faculté de Médecine Saint-Antoine, 27, rue de Chaligny, F75571 Paris.

Presse Medicale (Paris, France : 1983)
|July 4, 2001
PubMed
Summary
This summary is machine-generated.

Phase I clinical trials assess new drug safety, pharmacodynamics, and pharmacokinetics in humans. Data from these initial studies are vital for subsequent patient trials and risk-benefit assessments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of atrial fibrillation in France: the observational FACTUEL study].

Annales de cardiologie et d'angeiologie·2009
Same author

[Treating heart failure with carvedilol in private practice (initiating treatment and follow-up at one year. The KEOPS study].

Archives des maladies du coeur et des vaisseaux·2007
Same author

Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics.

Clinical pharmacology and therapeutics·2007
Same author

[Flecainide acetate utilisation review among general practitioners and hospital or office-based cardiologists in France. Obepine: observational study of flecainide].

Annales de cardiologie et d'angeiologie·2006
Same author

[Flecainide controlled-release for prevention of atrial fibrillation relapse].

Archives des maladies du coeur et des vaisseaux·2006
Same author

[AFFIRM: what we have learned ... and pending issues].

Annales de cardiologie et d'angeiologie·2005
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Pharmacology
  • Clinical Research
  • Drug Development

Context:

  • Phase I clinical trials represent the first administration of novel therapeutic agents to humans.
  • These trials are essential for understanding how a drug behaves in the body.

Purpose:

  • To assess the safety and tolerability of new drugs.
  • To elucidate the pharmacodynamics and pharmacokinetics of investigational medicinal products.
  • To identify metabolic and excretory pathways in the human organism.

Summary:

  • Phase I trials involve healthy volunteers, with exceptions for drugs with known toxicity like anti-cancer agents.
  • Legal regulations, such as French law of December 20, 1988, govern these trials.
  • Data gathered are critical for subsequent trial phases.

Related Experiment Videos

Impact:

  • Provides foundational data for Phase II and III trials.
  • Enables informed decisions regarding a drug's risk-benefit profile.
  • Facilitates the progression of new drug candidates through the development pipeline.